ArticleInvestigative ophthalmology & visual science2025
Permanent Senescence Via p16 Leads to Guttae Formation in an In Vitro Human Corneal Endothelial Cell Model.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting RhoA/ROCK Signaling to Modulate Extracellular Matrix Remodeling in Corneal Endothelial Dystrophies.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Fuchs endothelial corneal dystrophy (FECD) is characterized by corneal endothelial cell (CEnC) degeneration and excessive extracellular matrix (ECM) deposition. FECD is an age-related disorder manifested by upregulation of senescence markers. However, the association between senescence and pathological ECM accumulation remains unclear. This study investigated whether senescence mediated cell-cycle arrest drives aberrant ECM deposition and guttae formation in FECD. Methods: A chronic stress (CS) model was established by concurrently exposing immortalized human CEnCs to ultraviolet-A light (UVA; 25 J/cm2) and 4-hydroxyestradiol (4OHE2; 20 µM) on days 1, 6, and 21, followed by approximately a 60-day recovery period. In vitro guttae were characterized using brightfield microscopy, scanning electron microscopy (SEM), immunofluorescence, and compared with FECD specimens. Cell cycle dynamics, senescence markers, and ECM expression were assessed using flow-cytometry, cell sorting, immunostaining, ELISA, and RT-PCR. Results: In vitro guttae displayed characteristic morphology and ultrastructural similarity to FECD guttae. CS-exposed CEnCs showed significant CDKN2A upregulation (42-fold, P < 0.01) and increased p16 positivity (63 ± 12% vs. 7 ± 3% in controls, P < 0.0001), indicating senescence. Flow cytometry revealed accumulation of CS cells in G0/G1 (74 ± 6% vs. 57 ± 3%, P < 0.0001) phase. G0/G1 sorted p16+ cells exhibited upregulation of COL4A1 (188-fold, P < 0.0001) and LAMB1 (98-fold, P < 0.05). Immunostaining confirmed p16 colocalization with COL4A1 and LAMB1 in CS cells and FECD tissues. ELISA showed elevated levels of TGFBIp in the conditioned media obtained from CS-exposed cells. Conclusions: G0/G1-arrested p16+ve senescent CEnCs promote pathological ECM deposition and guttae formation. This model, integrating environmental, hormonal, and aging factors, provides a biologically relevant platform for studying FECD and testing therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.